Almac Group Hosts Official Visit by British Deputy Consul General

February 22, 2017

Global organisation congratulated for celebrating 20 years in North America

Souderton, P.A., 21st February 2017Almac Group, the global contract pharmaceutical development and manufacturing organisation, was delighted to host an official visit by the British Consulate on Tuesday 21st February to its state-of-the-art US headquarters in Souderton.

Almac recently marked 20 years in the US and, in November, the Group announced it was investing $25 million to expand its 240,000-square-foot facility in Souderton.

The expansion project involves substantial investment in new machine lines, computer equipment, software and an expanded cold storage area and will create 312 jobs across a wide range of functions and increases capabilities for its Sciences, Clinical Services, Clinical Technologies and Pharma Services businesses.

Ross Allen, Deputy Consul General and US Director of the Department for International Trade was accompanied by John Hoggard, Vice Consul and US Healthcare Sector Lead, at the meeting at Souderton.  Mark Weir, Almac’s US Group Financial Controller, presented a comprehensive overview of Almac’s history, global presence, and US operations which was followed by a private tour of the manufacturing facility provided by Rich Segiel, Vice President, Business Development, Almac Clinical Services.

For almost 50 years, Almac, which is headquartered in Craigavon, Northern Ireland, has been delivering the most comprehensive range of integrated drug development services available to the pharmaceutical and biopharmaceutical industry. The Group first established a presence in the US in 1996 with the opening of its clinical trial operations in Audubon, Pennsylvania.  By 2000, Almac had expanded its North American presence into North Carolina through the acquisition of Applied Clinical Concepts Inc (ACCI) and Duke Clinical Research Institute Pharmacy (DCRIP) which merged to form Almac Clinical Services based in the Research Triangle Park, Durham.

Mark Weir commented: “We are delighted to have the opportunity to meet with the Vice Consul and Deputy Consul General today and showcase our facility and capabilities, right here in Pennsylvania.  Our commitment to the PA State was strengthened in November when we announced a $25 million investment to expand our operations both here and in Lansdale, creating over 300 new jobs, and we very much look forward to continuing our success in the US.”

“I am extremely impressed by the Almac team and their Souderton facility. Almac has a very interesting history and a focused mission” said Ross Allen. “The team are really passionate about their jobs, and rightly so: they are doing some great work that ultimately benefits huge numbers of patients. Almac has found there is an opportunity for their unique services and, in so doing, is bringing jobs and prosperity to both the UK and US.”

By expanding its operations in Europe and North America Almac’s global headcount is expected to reach 5,000 this year. The company is currently seeking exceptional, high-skilled individuals to fill roles at Souderton in areas including IT, business development, quality, production and project management. More information at



For further information:

About Almac Group
‘Partnering to Advance Human Health’

The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation that has organically grown over 40 years and now employs in excess of 4,500 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).

About Department of International Trade

The UK’s Department for International Trade (DIT) has overall responsibility for promoting UK trade across the world and attracting foreign investment to the UK. We are a specialised government department with responsibility for negotiating international trade policy, supporting business, as well as delivering an outward-looking trade diplomacy strategy.

To find out how to grow your global business click here.


Back to news